id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA_FRDOC_0001-0508,DEA,DEA_FRDOC_0001,Designation of Propionyl Chloride as a List I Chemical,Rule,,2026-03-10T04:00:00Z,2026,3,2026-03-10T04:00:00Z,,2026-03-10T16:55:22Z,2026-04657,0,0,09000064b9206be3
DEA_FRDOC_0001-0507,DEA,DEA_FRDOC_0001,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act",Rule,,2026-03-02T05:00:00Z,2026,3,2026-03-02T05:00:00Z,,2026-03-02T18:40:50Z,2026-04112,0,0,09000064b91e8fdf
DEA_FRDOC_0001-0506,DEA,DEA_FRDOC_0001,Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017,Rule,,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,,2026-02-05T17:30:25Z,2026-02288,0,0,09000064b919298b
DEA_FRDOC_0001-0330,DEA,DEA_FRDOC_0001,Samidorphan_DEA_8F analysis_10-15-2020,Supporting & Related Material,,2020-12-10T00:00:00Z,2020,12,,,2022-07-19T12:59:45Z,,0,1,0900006484995f8f
DEA_FRDOC_0001-0329,DEA,DEA_FRDOC_0001,HHS Samidorphan 2020 01-09,Supporting & Related Material,,2020-12-10T00:00:00Z,2020,12,,,2022-07-19T13:00:03Z,,0,1,0900006484995f8b